Executive Director, Global Kidney Commercial Strategy

Vertex Pharmaceuticals LLC; Boston (MA); Hybrid; USD 261,000 - 391,000; Full time

Benefits offered by this job

Medical, dental, vision benefits

Paid time off

Educational assistance programs

Commuting subsidy

401(k)

Equity and annual bonus

Job summary

Vertex Pharmaceuticals LLC in Boston seeks an Executive Director, GCS Kidney - POVE to lead povetacicept commercial strategy for kidney indications including IgAN and pMN. You will guide global launch planning, lifecycle management, and cross-functional decisions across development, evidence generation, and investment priorities.

The role requires driving US launch readiness, shaping market access, and coordinating with regional teams to maximize patient impact and long-term value.

Qualifications

• Extensive biopharmaceutical commercial experience including global strategy and marketing leadership.
• Experience leading global launch strategy and execution for specialty or rare disease products.
• Strong experience in lifecycle management, forecast, and evidence strategy.

Responsibilities

• Co-lead the Kidney Program Team to set strategy and priorities across IgAN and pMN.
• Own global commercial strategy for povetacicept in kidney and coordinate launch readiness.
• Lead global launch execution and lifecycle management in IgAN and develop pMN commercialization plans.
• Collaborate with Development, Medical, Regulatory, Value & Access, and regional teams to ensure global alignment.

Skills

Global commercial strategy

Launch strategy and execution

Lifecycle management

Leadership

Nephrology/kidney market knowledge

Education

Bachelor’s degree in business, marketing, life sciences, healthcare, or related field

MBA or advanced degree preferred

Job description

Vertex Pharmaceuticals LLC in Boston seeks an Executive Director, GCS Kidney - POVE to lead povetacicept commercial strategy for kidney indications including IgAN and pMN. You will guide global launch planning, lifecycle management, and cross-functional decisions across development, evidence generation, and investment priorities.

The role requires driving US launch readiness, shaping market access, and coordinating with regional teams to maximize patient impact and long-term value.